The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
Pharmacology and Therapeutics of Bronchodilators
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma
Program, P., & theDiagnosis, T. E. P. O. (1997) · Cited by 4,083
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Global strategy for asthma management and prevention: GINA executive summary
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138707 · Cited by 3,203
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
(2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.029 · Cited by 2,181
Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Brochard, L., Mancebo, J., Wysocki, M., Lofaso, F., Conti, G., Rauss, A., Simonneau, G., Benito, S., Gasparetto, A., Lemaire, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331301 · Cited by 2,057
SOMLYO, A. P., & SOMLYO, A. V. (2003) · Physiological Reviews · doi:10.1152/physrev.00023.2003 · Cited by 1,991
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
The Salmeterol Multicenter Asthma Research Trial
Nelson, H. S., Weiss, S. T., Bleecker, E. R., Yancey, S. W., & Dorinsky, P. M. (2006) · Chest · doi:10.1378/chest.129.1.15 · Cited by 1,114
THE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
Krupnick, J. G., & Benovic, J. L. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.289 · Cited by 1,103
Regular inhaled beta-agonist treatment in bronchial asthma
Sears, M. R., Taylor, D. R., Print, C. G., Lake, D. C., Li, Q., Flannery, E. M., Yates, D. M., Lucas, M. K., & Herbison, G. P. (1990) · The Lancet · doi:10.1016/0140-6736(90)93098-a · Cited by 1,065
Drysdale, C. M., McGraw, D. W., Stack, C. B., Stephens, J. C., Judson, R. S., Nandabalan, K., Arnold, K., Ruano, G., & Liggett, S. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10483 · Cited by 964
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Calverley, P. M., Rabe, K. F., Goehring, U.-M., Kristiansen, S., Fabbri, L. M., & Martinez, F. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61255-1 · Cited by 829
Green, S. A., Turki, J., Innis, M., & Liggett, S. B. (1994) · Biochemistry · doi:10.1021/bi00198a006 · Cited by 772
Aging Biology and Geriatric Clinical Pharmacology
McLean, A. J., & Le Couteur, D. G. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.4 · Cited by 771
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506576200 · Cited by 759
Celli, B. R., Thomas, N. E., Anderson, J. A., Ferguson, G. T., Jenkins, C. R., Jones, P. W., Vestbo, J., Knobil, K., Yates, J. C., & Calverley, P. M. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1869oc · Cited by 748
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Vogelmeier, C., Hederer, B., Glaab, T., Schmidt, H., Rutten-van Mölken, M. P. M. H., Beeh, K. M., Rabe, K. F., & Fabbri, L. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008378 · Cited by 684
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
Reiter, E., & Lefkowitz, R. J. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.008 · Cited by 666
Deshpande, D. A., Wang, W. C. H., McIlmoyle, E. L., Robinett, K. S., Schillinger, R. M., An, S. S., Sham, J. S. K., & Liggett, S. B. (2010) · Nature Medicine · doi:10.1038/nm.2237 · Cited by 662
Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
Aaron, S. D., Vandemheen, K. L., Fergusson, D., Maltais, F., Bourbeau, J., Goldstein, R., Balter, M., O'Donnell, D., McIvor, A., Sharma, S., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00152 · Cited by 649
Rational Intravenous Doses of Theophylline
Mitenko, P. A., & Ogilvie, R. I. (1973) · New England Journal of Medicine · doi:10.1056/nejm197309202891202 · Cited by 647
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
Warne, T., Moukhametzianov, R., Baker, J. G., Nehmé, R., Edwards, P. C., Leslie, A. G. W., Schertler, G. F. X., & Tate, C. G. (2011) · Nature · doi:10.1038/nature09746 · Cited by 618
Mutations in the Gene Encoding for the β 2 -adrenergic Receptor in Normal and Asthmatic Subjects
Reihsaus, E., Innis, M., MacIntyre, N., & Liggett, S. B. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/8.3.334 · Cited by 617
Fabbri, L. M., Calverley, P. M., Izquierdo-Alonso, J. L., Bundschuh, D. S., Brose, M., Martinez, F. J., & Rabe, K. F. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61252-6 · Cited by 614
Martinez, F. D., Graves, P. E., Baldini, M., Solomon, S., & Erickson, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119874 · Cited by 605
Israel, E., Chinchilli, V. M., Ford, J. G., Boushey, H. A., Cherniack, R., Craig, T. J., Deykin, A., Fagan, J. K., Fahy, J. V., Fish, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17273-5 · Cited by 602
ISRAEL, E., DRAZEN, J. M., LIGGETT, S. B., BOUSHEY, H. A., CHERNIACK, R. M., CHINCHILLI, V. M., COOPER, D. M., FAHY, J. V., FISH, J. E., FORD, J. G., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.1.9907092 · Cited by 549
Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential
Ichinose, F., Roberts, J. D., & Zapol, W. M. (2004) · Circulation · doi:10.1161/01.cir.0000134595.80170.62 · Cited by 540
Ito, K., Lim, S., Caramori, G., Cosio, B., Chung, K. F., Adcock, I. M., & Barnes, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132556899 · Cited by 512
Benovic, J. L., Kühn, H., Weyand, I., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.8879 · Cited by 482
Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
Cosio, B. G., Tsaprouni, L., Ito, K., Jazrawi, E., Adcock, I. M., & Barnes, P. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040416 · Cited by 473
Beta-adrenergic receptors and their regulation.
Barnes, P. J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663795 · Cited by 468
Olshansky, B., Sabbah, H. N., Hauptman, P. J., & Colucci, W. S. (2008) · Circulation · doi:10.1161/circulationaha.107.760405 · Cited by 456
Theophylline: New Perspectives for an Old Drug
Barnes, P. J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1142pp · Cited by 435
Welte, T., Miravitlles, M., Hernandez, P., Eriksson, G., Peterson, S., Polanowski, T., & Kessler, R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0492oc · Cited by 408
Anti-inflammatory effects of low-dose oral theophylline in atopic asthma
Sullivan, P., Jaffar, Z., Page, C., Costello, J., Bekir, S., & Jeffery, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90127-9 · Cited by 403
Self-citationAminophylline Improves Diaphragmatic Contractility
Aubier, M., De Troyer, A., Sampson, M., Macklem, P. T., & Roussos, C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107303050503 · Cited by 399
JOHNSON, M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.supplement_2.13tac110 · Cited by 397
Binkley, P. F., Nunziata, E., Haas, G. J., Nelson, S. D., & Cody, R. J. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90602-6 · Cited by 363
Inhaled nitric oxide for respiratory failure in preterm infants
Barrington, K. J., Finer, N., & Pennaforte, T. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000509.pub5 · Cited by 360
Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus Tiotropium
Donohue, J. F., Fogarty, C., Lötvall, J., Mahler, D. A., Worth, H., Yorgancioğlu, A., Iqbal, A., Swales, J., Owen, R., Higgins, M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200910-1500oc · Cited by 358
To, Y., Ito, K., Kizawa, Y., Failla, M., Ito, M., Kusama, T., Elliott, W. M., Hogg, J. C., Adcock, I. M., & Barnes, P. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0937oc · Cited by 352
Evans, D. J., Taylor, D. A., Zetterstrom, O., Chung, K. F., O'Connor, B. J., & Barnes, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372002 · Cited by 348
Taylor, D. R. (2000) · Thorax · doi:10.1136/thorax.55.9.762 · Cited by 347
Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild Asthma
Drazen, J. M., Israel, E., Boushey, H. A., Chinchilli, V. M., Fahy, J. V., Fish, J. E., Lazarus, S. C., Lemanske, R. F., Martin, R. J., Peters, S. P., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609193351202 · Cited by 347
van Noord, J. A., Aumann, J.-L., Janssens, E., Smeets, J. J., Verhaert, J., Disse, B., Mueller, A., & Cornelissen, P. J. G. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00140404 · Cited by 341
Letter: Obstetric Delivery Today.
Chalmers, I. (1976) · PubMed · Cited by 337
JAGGAR, WELLMAN, HEPPNER, PORTER, PEREZ, GOLLASCH, KLEPPISCH, RUBART, STEVENSON, LEDERER, et al. (1998) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1998.00462.x · Cited by 302
β-Adrenergic Receptor Polymorphisms and Response to Salmeterol
Wechsler, M. E., Lehman, E., Lazarus, S. C., Lemanske, R. F., Boushey, H. A., Deykin, A., Fahy, J. V., Sorkness, C. A., Chinchilli, V. M., Craig, T. J., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1519oc · Cited by 299
Busse, W. W. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.10.023 · Cited by 288
Inhalation of Nitric Oxide Modulates Adult Human Bronchial Tone
Högman, M., Frostell, C. G., Hedenström, H., & Hedenstierna, G. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.6_pt_1.1474 · Cited by 288
Vans, D. A. J. E., Aylor, D. A. A. T., Etterstrom, O. L. Z., Hung, K. F. A. C., & Arnes, P. E. J. B. (1997) · Cited by 284
Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue
Yang, Y. T., & McElligott, M. A. (1989) · Biochemical Journal · doi:10.1042/bj2610001 · Cited by 281
Wong, C. S., Pavord, I. D., Williams, J., Britton, J. R., & Tattersfield, A. E. (1990) · The Lancet · doi:10.1016/0140-6736(90)93099-b · Cited by 278
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
Carstairs, J. R., Nimmo, A. J., & Barnes, P. J. (1985) · PubMed · doi:10.1164/arrd.1985.132.3.541 · Cited by 278
Kerstjens, H. A. M., Disse, B., Schröder-Babo, W., Bantje, T. A., Gahlemann, M., Sigmund, R., Engel, M., & van Noord, J. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.039 · Cited by 276
Nannini, L. J., Poole, P., Milan, S. J., Holmes, R., & Normansell, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003794.pub4 · Cited by 274
Dahl, R., Chung, K. F., Buhl, R., Magnussen, H., Nonikov, V., Jack, D., Bleasdale, P., Owen, R., Higgins, M., Kramer, B., et al. (2010) · Thorax · doi:10.1136/thx.2009.125435 · Cited by 273
Short, P. M., Lipworth, S. I. W., Elder, D. H. J., Schembri, S., & Lipworth, B. J. (2011) · BMJ · doi:10.1136/bmj.d2549 · Cited by 270
Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol
Ramage, L., Lipworth, B. J., Ingram, C. G., Cree, I. A., & Dhillon, D. P. (1994) · Respiratory Medicine · doi:10.1016/0954-6111(94)90042-6 · Cited by 268
Nannini, L. J., Lasserson, T. J., & Poole, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006829.pub2 · Cited by 264
Goldie, R. G., Spina, D., Henry, P. J., Lulich, K. M., & Paterson, J. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb02956.x · Cited by 263
Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD
ZuWallack, R. L., Mahler, D. A., Reilly, D., Church, N., Emmett, A., Rickard, K., & Knobil, K. (2001) · Chest · doi:10.1378/chest.119.6.1661 · Cited by 258
Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies
Bracken, M. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00621-5 · Cited by 257
Muscarinic receptor subtypes in airways
Barnes, P. J. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90310-y · Cited by 255
(1857) · Scientific American · doi:10.1038/scientificamerican01171857-149a · Cited by 250
LIMA, J., THOMASON, D., MOHAMED, M., EBERLE, L., SELF, T., & JOHNSON, J. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70071-8 · Cited by 250
The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma
Chowdhury, B. A., & Dal Pan, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1002074 · Cited by 249
Reflex regulation of airway smooth muscle tone
Canning, B. J. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00313.2006 · Cited by 246
The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD
Cazzola, M., & Molimard, M. (2010) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.03.003 · Cited by 241
Self-citationPharmacokinetics of Theophylline in Children With Asthma
Ellis, E. F., Koysooko, R., & Levy, G. (1976) · Pediatrics · doi:10.1542/peds.58.4.542 · Cited by 238
Choudry, N. B., Fuller, R. W., & Pride, N. B. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.1.137 · Cited by 234
Singh, S., Loke, Y. K., Enright, P. L., & Furberg, C. D. (2011) · BMJ · doi:10.1136/bmj.d3215 · Cited by 227
Sears, M. R. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129966 · Cited by 223
Bleecker, E. R., Postma, D. S., Lawrance, R. M., Meyers, D. A., Ambrose, H. J., & Goldman, M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61906-0 · Cited by 222
LITTNER, M. R., ILOWITE, J. S., TASHKIN, D. P., FRIEDMAN, M., SERBY, C. W., MENJOGE, S. S., & WITEK, T. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9903044 · Cited by 221
Behrens, M., Foerster, S., Staehler, F., Raguse, J.-D., & Meyerhof, W. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1168-07.2007 · Cited by 216
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison
Kornmann, O., Dahl, R., Centanni, S., Dogra, A., Owen, R., Lassen, C., & Kramer, B. (2011) · European Respiratory Journal · doi:10.1183/09031936.00045810 · Cited by 213
Wechsler, M. E., Kunselman, S. J., Chinchilli, V. M., Bleecker, E., Boushey, H. A., Calhoun, W. J., Ameredes, B. T., Castro, M., Craig, T. J., Denlinger, L., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61492-6 · Cited by 212
van Noord, J. A., de Munck, D. R. A. J., Bantje, T. A., Hop, W. C. J., Akveld, M. L. M., & Bommer, A. M. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15e11.x · Cited by 211
Belmonte, K. E. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-043sr · Cited by 210
Compton, C. H., Gubb, J., Nieman, R., Edelson, J., Amit, O., Bakst, A., Ayres, J. G., Creemers, J. P., Schultze-Werninghaus, G., Brambilla, C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05481-2 · Cited by 208
van Noord, J. A., Aumann, J. L., Janssens, E., Verhaert, J., Smeets, J. J., Mueller, A., & Cornelissen, P. J. G. (2006) · Chest · doi:10.1378/chest.129.3.509 · Cited by 203
Fitch, K. D., Sue-Chu, M., Anderson, S. D., Boulet, L.-P., Hancox, R. J., McKenzie, D. C., Backer, V., Rundell, K. W., Alonso, J. M., Kippelen, P., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.07.003 · Cited by 197
Muscarinic acetylcholine receptors and airway diseases
Coulson, F. R., & Fryer, A. D. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00004-4 · Cited by 196
Treatment Effects of Low-Dose Theophylline Combined With an Inhaled Corticosteroid in COPD
Ford, P. A., Durham, A. L., Russell, R. E. K., Gordon, F., Adcock, I. M., & Barnes, P. J. (2010) · Chest · doi:10.1378/chest.09-2363 · Cited by 190
Ducharme, F. M., Ni Chroinin, M., Greenstone, I., & Lasserson, T. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005535.pub2 · Cited by 185
Ducharme, F. M., Ni Chroinin, M., Greenstone, I., & Lasserson, T. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005533.pub2 · Cited by 185
Cardiovascular Safety of Tiotropium in Patients With COPD
Celli, B., Decramer, M., Leimer, I., Vogel, U., Kesten, S., & Tashkin, D. P. (2010) · Chest · doi:10.1378/chest.09-0011 · Cited by 184
Anderson, G. P. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90729-m · Cited by 184
Neural regulation of airway smooth muscle tone
Canning, B. J., & Fischer, A. (2001) · Respiration Physiology · doi:10.1016/s0034-5687(00)00208-5 · Cited by 183
β-Adrenoceptor agonists and asthma—100 years of development
Waldeck, B. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01728-4 · Cited by 180
Singh, D., Brooks, J., Hagan, G., Cahn, A., & O'Connor, B. J. (2008) · Thorax · doi:10.1136/thx.2007.087213 · Cited by 177
Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
D'Urzo, A., Ferguson, G. T., van Noord, J. A., Hirata, K., Martin, C., Horton, R., Lu, Y., Banerji, D., & Overend, T. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-156 · Cited by 176
Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study
Vogelmeier, C., Kardos, P., Harari, S., Gans, S. J. M., Stenglein, S., & Thirlwell, J. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.07.020 · Cited by 172
Dose response relation to oral theophylline in severe chronic obstructive airways disease.
Chrystyn, H., Mulley, B. A., & Peake, M. D. (1988) · BMJ · doi:10.1136/bmj.297.6662.1506 · Cited by 170
Lee, T. A., Pickard, A. S., Au, D. H., Bartle, B., & Weiss, K. B. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-6-200809160-00004 · Cited by 170
Kume, H., Graziano, M. P., & Kotlikoff, M. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11051 · Cited by 168
Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP
Laburthe, M., & Couvineau, A. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00099-x · Cited by 162
Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities
Doe, C. P., Bentley, R. G., Behm, D. J., Lafferty, R., Stavenger, R. A., Jung, D. K., Bamford, M. J., Panchal, T. A., Grygielko, E. T., Wright, L. L., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110635 · Cited by 161
Autonomic Innervation of Human Airways: Structure, Function, and Pathophysiology in Asthma
van der Velden, V. H. J., & Hulsmann, A. R. (1999) · NeuroImmunoModulation · doi:10.1159/000026376 · Cited by 161
β2‐adrenoceptor agonists: current and future direction
Cazzola, M., Calzetta, L., & Matera, M. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01216.x · Cited by 158
Self-citationPast, present and future— β2 -adrenoceptor agonists in asthma management
Sears, M. R., & Lötvall, J. O. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.07.003 · Cited by 158
Palmer, C. N. A., Lipworth, B. J., Lee, S. L., Ismail, T., MacGregor, D., & Mukhopadhyay, S. (2006) · Thorax · doi:10.1136/thx.2006.059386 · Cited by 157
The pharmacology of salmeterol
Johnson, M. W., Butchers, P. R., Coleman, R. A., et al. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90728-l · Cited by 154
Bleecker, E. R., Yancey, S. W., Baitinger, L., Edwards, L. D., Klotsman, M., Anderson, W. H., & Dorinsky, P. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.06.036 · Cited by 153
Effect of Inhaled PGE2 on Exercise-Induced Bronchoconstriction in Asthmatic Subjects
Melillo, E., Woolley, K. L., Manning, P. J., et al. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173753 · Cited by 152
Cazzola, M., Matera, M. G., Santangelo, G., Vinciguerra, A., Rossi, F., & D’Amato, G. (1995) · Respiratory Medicine · doi:10.1016/0954-6111(95)90008-x · Cited by 151
Self-citationSustained Activation of a G Protein-coupled Receptor via “Anchored” Agonist Binding
Green, S. A., Spasoff, A. P., Coleman, R. A., Johnson, M. W., & Liggett, S. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24029 · Cited by 151
Nassenstein, C., Braun, A. C., Erpenbeck, V. J., Lommatzsch, M., Schmidt, S., Krug, N., Luttmann, W., Renz, H. E., & Virchow, J. C., Jr. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20010897 · Cited by 150
Routine Nebulized Ipratropium and Albuterol Together Are Better Than Either Alone in COPD
† (1997) · CHEST Journal · doi:10.1378/chest.112.6.1514 · Cited by 148
Theophylline in Chronic Obstructive Pulmonary Disease: New Horizons
Barnes, P. J. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-024sr · Cited by 146
Battram, C., Charlton, S. J., Cuenoud, B., Dowling, M. R., Fairhurst, R. A., Farr, D., Fozard, J. R., Leighton-Davies, J. R., Lewis, C. A., McEvoy, L., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098251 · Cited by 145
Inhaled Nitric Oxide. A Bronchodilator in Mild Asthmatics With Methacholine-Induced Bronchospasm
Kacmarek, R. M., Ripple, R. E., Cockrill, B. A., Bloch, K. J., Zapol, W. M., & Johnson, D. C. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.1.8542105 · Cited by 143
Cazzola, M., Marco, F. D., Santus, P., Boveri, B., Verga, M., Matera, M. G., & Centanni, S. (2003) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2003.09.001 · Cited by 141
Self-citationβ2-Agonist Tolerance and Exercise-induced Bronchospasm
Hancox, R. J., Subbarao, P., Kamada, D., Watson, R. M., Hargreave, F. E., & Inman, M. D. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.8.200111-091bc · Cited by 141
Regular treatment with formoterol for chronic asthma: serious adverse events
Cates, C. J., & Cates, M. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006923.pub3 · Cited by 141
McDaniel, N. L., Chen, X. L., Singer, H. A., Murphy, R. A., & Rembold, C. M. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.263.2.c461 · Cited by 141
Casarosa, P., Bouyssou, T., Germeyer, S., Schnapp, A., Gantner, F., & Pieper, M. P. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152470 · Cited by 140
Salbutamol in the 1980s: A Reappraisal of its Clinical Efficacy
Price, A. H., & Clissold, S. P. (1989) · Drugs · doi:10.2165/00003495-198938010-00004 · Cited by 139
The airway cholinergic system: physiology and pharmacology
Racké, K., & Matthiesen, S. (2004) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2004.03.001 · Cited by 139
Anticholinergic agents in asthma and COPD
Gross, N. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.072 · Cited by 139
Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD
Tashkin, D. P., Pearle, J. L., Iezzoni, D. G., & Varghese, S. T. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550902724073 · Cited by 139
Novel long‐acting bronchodilators for COPD and asthma
Cazzola, M., & Matera, M. G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.284 · Cited by 138
Self-citationBlinded 12-week comparison of once-daily indacaterol and tiotropium in COPD
Buhl, R., Dunn, L., Disdier, C., Lassen, C., Amos, C., Henley, M., & Krämer, B. (2011) · European Respiratory Journal · doi:10.1183/09031936.00191810 · Cited by 138
Inhaled ??2-Adrenoceptor Agonists
Cazzola, M., Matera, M. G., & Donner, C. F. (2005) · Drugs · doi:10.2165/00003495-200565120-00001 · Cited by 135
Self-citationPlotnick, L. H., & Ducharme, F. M. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000060 · Cited by 132
ARG1 Is a Novel Bronchodilator Response Gene
Litonjua, A. A., Lasky-Su, J. A., Schneiter, K., Tantisira, K. G., Lazarus, R. M., Klanderman, B. J., Lima, J. J., Irvin, C. G., Peters, S. P., Hanrahan, J. P., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1363oc · Cited by 131
Gavaldà, A., Miralpeix, M., Ramos, I., Otal, R., Carreño, C., Viñals, M., Domènech, T., Carcasona, C., Reyes, B., Vilella, D., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151639 · Cited by 129
McGraw, D. W., Almoosa, K. F., Paul, R. J., Kobilka, B. K., & Liggett, S. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18193 · Cited by 128
Chung, K. F., Caramori, G., & Adcock, I. M. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0682-z · Cited by 128
Prostaglandin E2 Mediates Cough via the EP3 Receptor: Implications for Future Disease Therapy
Maher, S. A., Birrell, M. A., & Belvisi, M. G. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0388oc · Cited by 126
Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD
Chapman, K. R., Rennard, S. I., Dogra, A., Owen, R. J., Lassen, C., & Krämer, B. (2011) · CHEST Journal · doi:10.1378/chest.10-1830 · Cited by 125
Scheinin, M., Koulu, M., Laurikainen, E. A., & Allonen, H. O. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03224.x · Cited by 125
Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation
Zhang, Z., & Kaminsky, L. S. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00120-o · Cited by 124
Spears, M., Donnelly, I., Jolly, L., Brannigan, M., Ito, K., McSharry, C. P., Lafferty, J., Chaudhuri, R., Braganza, G., Adcock, I. M., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00158208 · Cited by 122
Control by cholinergic mechanisms
Racké, K., Juergens, U. R., & Matthiesen, S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.050 · Cited by 120
Feldman, G., Siler, T. M., Prasad, N., Jack, D., Piggott, S., Owen, R. J., Higgins, M., Krämer, B., & the INLIGHT 1† study group (2010) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-10-11 · Cited by 118
Carlsen, K. H., Anderson, S. D., Bjermer, L. H., Bonini, S., Brusasco, V., Canonica, G. W., Cummiskey, J. M., Delgado, L., Giacco, S. R. D., Drobnic, F., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01663.x · Cited by 117
D’Urzo, A. D., Salvo, M. C. D., Ramírez‐Rivera, A., Almeida, J., Sichletidis, L. T., Rapatz, G., & Kottakis, J. (2001) · CHEST Journal · doi:10.1378/chest.119.5.1347 · Cited by 117
Au, D. H., Udris, E. M., Fan, V. S., Curtis, J. R., McDonell, M. B., & Fihn, S. D. (2003) · CHEST Journal · doi:10.1378/chest.123.6.1964 · Cited by 115
Ryall, J. G., Sillence, M. N., & Lynch, G. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706669 · Cited by 113
Sturton, R. G., Trifilieff, A., Nicholson, A. G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.129296 · Cited by 113
Ultra long-acting β2-agonists in development for asthma and chronic obstructive pulmonary disease
Cazzola, M., Matera, M. G., & Lötvall, J. O. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.7.775 · Cited by 112
Self-citationGuideline-concordant therapy and outcomes in healthcare-associated pneumonia
Attridge, R. T., Frei, C. R., Restrepo, M. I., Lawson, K. A., Ryan, L., Pugh, M. J., Anzueto, A., & Mortensen, E. M. (2011) · European Respiratory Journal · doi:10.1183/09031936.00141110 · Cited by 112
EP4 receptor as a new target for bronchodilator therapy
Buckley, J., Birrell, M. A., Maher, S. A., Nials, A. T., Clarke, D. L., & Belvisi, M. (2011) · Thorax · doi:10.1136/thx.2010.158568 · Cited by 112
Effect of indacaterol on exercise endurance and lung hyperinflation in COPD
O’Donnell, D. E., Casaburi, R., Vincken, W., Puente-Maestu, L., Swales, J., Lawrence, D., & Kramer, B. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.03.014 · Cited by 109
Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials
Sears, M. R., Ottosson, A., Radner, F., & Suissa, S. (2008) · European Respiratory Journal · doi:10.1183/09031936.00145006 · Cited by 109
The Safety of Long-Acting β-Agonists among Patients with Asthma Using Inhaled Corticosteroids
Jaeschke, R., O’Byrne, P. M., Mejza, F., Nair, P. K., Leśniak, W., Brożek, J., Thabane, L., Cheng, J., Schünemann, H. J., Sears, M. R., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-494oc · Cited by 108
The use of newer asthma and allergy medications during pregnancy
Callaghan, M. L. (2000) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62505-7 · Cited by 108
β2-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone Propionate
Bleecker, E. R., Nelson, H. S., Kraft, M., Corren, J., Meyers, D. A., Yancey, S. W., Anderson, W. H., Emmett, A. H., & Ortega, H. G. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/200809-1511oc · Cited by 108
Assessing the Safety of Adding LABAs to Inhaled Corticosteroids for Treating Asthma
Chowdhury, B. A., Seymour, S. M., & Levenson, M. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1104375 · Cited by 107
Are phosphodiesterase 4 inhibitors just more theophylline?
Boswell‐Smith, V., Cazzola, M., & Page, C. P. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.045 · Cited by 107
Self-citationBasu, K., Palmer, C. N. A., Tavendale, R., Lipworth, B. J., & Mukhopadhyay, S. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.043 · Cited by 107
Marwick, J. A., Caramori, G., Casolari, P., Mazzoni, F., Kirkham, P., Adcock, I. M., Chung, K. F., & Papi, A. A. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.003 · Cited by 106
β 2 -Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model
Nguyễn, L., Lin, R. J., Parra, S., Omoluabi, O., Hanania, N. A., Tuvim, M. J., Knoll, B. J., Dickey, B. F., & Bond, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810902106 · Cited by 106
New perspectives regarding β2‐adrenoceptor ligands in the treatment of asthma
Walker, J. K. L., Penn, R., Hanania, N. A., Dickey, B. F., & Bond, R. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01178.x · Cited by 105
The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist
Baur, F., Beattie, D., Beer, D., Bentley, D., Bradley, M. E., Bruce, I., Charlton, S. J., Cuenoud, B. M., Ernst, R., Fairhurst, R. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100068m · Cited by 103
Cazzola, M., Andò, F., Santus, P., Ruggeri, P., Marco, F. D., Sanduzzi, A., & D’Amato, M. (2006) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2006.06.001 · Cited by 102
Self-citationHYPOKALAEMIA INDUCED BY INHALATION OF FENOTEROL
Haalboom, J. R. E., Deenstra, M., & Struyvenberg, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92432-8 · Cited by 102
Use of Inhaled Anticholinergic Agents in Obstructive Airway Disease
Restrepo, R. D. (2007) · Respiratory Care · doi:10.4187/respcare.07520833 · Cited by 101
Regular inhaled salbutamol and asthma control: the TRUST randomised trial
Dennis, S. M., Sharp, S. J., Vickers, M. R., Frost, C. D., Crompton, G. K., Barnes, P. J., & Lee, T. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02238-8 · Cited by 101
Philipson, L. H. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129702 · Cited by 99 · cited 2×
“When given by inhalation, these agents are as effective as atropine at improving lung function but longer acting and much less prone to side effects (Gross, 2006).”
BackgroundMolecular interactions between glucocorticoids and long-acting β2-agonists
Adcock, I. M., Maneechotesuwan, K., & Usmani, O. S. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129705 · Cited by 99
The Chemotactic Activity of Sputum from Patients with Bronchiectasis
Mikami, M., Llewellyn-Jones, C. G., Bayley, D., Hill, S. L., & STOCKLEY, R. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9606120 · Cited by 98
Ion channel regulation of intracellular calcium and airway smooth muscle function
Perez‐Zoghbi, J. F., Karner, C., Ito, S., Shepherd, M. C., Alrashdan, Y., & Sanderson, M. J. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.09.006 · Cited by 98
Impaired Bronchodilator Response to Albuterol in Healthy Elderly Men and Women
Connolly, M. J., Crowley, J. J., Charan, N. B., Nielson, C., & Vestal, R. E. (1995) · CHEST Journal · doi:10.1378/chest.108.2.401 · Cited by 97
Jack, D. B. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05571.x · Cited by 96
Fuhr, R., MAGNUSSEN, H., Sarem, K., Llovera, A. R., Kirsten, A., Falqués, M., Caracta, C. F., & Gil, E. G. (2011) · CHEST Journal · doi:10.1378/chest.11-0406 · Cited by 96
Bouyssou, T., Casarosa, P., Naline, E., Pestel, S., Konetzki, I., Devillier, P., & Schnapp, A. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167007 · Cited by 95
Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study
Korn, S., Kerwin, E., Naycı, S. A., Amos, C., Owen, R. J., & Lassen, C. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.02.008 · Cited by 94
Nannini, L. J., Cates, C. J., Lasserson, T., & Poole, P. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003794.pub2 · Cited by 94
Novel bronchodilators for the treatment of chronic obstructive pulmonary disease
Matera, M. G., Page, C. P., & Cazzola, M. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.04.003 · Cited by 93
Self-citationTheophylline induces neutrophil apoptosis through adenosine A2A receptor antagonism
Yasui, K., Agematsu, K., Shinozaki, K., et al. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.4.529 · Cited by 93
Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease
van Noord, J. A., Smeets, J. J., Custers, F. L. J., Korducki, L., & Cornelissen, P. J. G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00238002 · Cited by 92
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events
Cates, C. J., Jaeschke, R., Schmidt, S., & Ferrer, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006922.pub3 · Cited by 92
Ionic mechanisms and Ca2+handling in airway smooth muscle
Hirota, S. A., Helli, P. B., & Janssen, L. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00147706 · Cited by 91
Nannini, L. J., Cates, C. J., Lasserson, T. J., & Poole, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003794.pub3 · Cited by 91
Lombardi, D., Cuenoud, B. M., & Krämer, S. D. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.10.001 · Cited by 90
Fardon, T. C., Haggart, K., Lee, D. K. C., & Lipworth, B. J. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.11.001 · Cited by 90
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
Singh, D., Pétavy, F., MacDonald, A. J., Lazaar, A. L., & O'Connor, B. J. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-26 · Cited by 90
Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function
Hamad, A. M., Clayton, A., Islam, M. B., & Knox, A. J. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00033.2003 · Cited by 90
Rho kinase inhibitors: A novel therapeutical intervention in asthma?
Schaafsma, D., Gosens, R., Zaagsma, J., Halayko, A. J., & Meurs, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.056 · Cited by 90
Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
Jones, P., Rennard, S. I., Agustí, A. G. N., Chanez, P., MAGNUSSEN, H., Fabbri, L. M., Donohue, J. F., Bateman, E. D., Gross, N. J., Lamarca, R., et al. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-55 · Cited by 89
Effects of clenbuterol on contractile and biochemical properties of skeletal muscle
DODD, S. L., Powers, S. K., Vrabas, I. S., Criswell, D. S., Stetson, S., & HUSSAIN, R. (1996) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199606000-00005 · Cited by 88
INTIME study investigators (INdacaterol & TIotropium: Measuring Efficacy), Vogelmeier, C. F., Ramos‐Barbón, D., Jack, D., Piggott, S., Owen, R. J., Higgins, M., & Krämer, B. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-135 · Cited by 88
Scatena, R., Bottoni, P., Pontoglio, A., & Giardina, B. (2009) · Current Medicinal Chemistry · doi:10.2174/092986710789957841 · Cited by 88
Emerging inhaled bronchodilators: an update
Cazzola, M., & Matera, M. G. (2009) · European Respiratory Journal · doi:10.1183/09031936.00013109 · Cited by 88
Self-citationGross, N. J. (2004) · CHEST Journal · doi:10.1378/chest.126.6.1946 · Cited by 87
Parasympathetic Control of Cardiac Sympathetic Activity
Azevedo, E. R., & Parker, J. D. (1999) · Circulation · doi:10.1161/01.cir.100.3.274 · Cited by 86
van Schayck, O. C. P., Folgering, H. T. M., Harbers, H. J. M., Maas, K. L., & van Weel, C. (1991) · Thorax · doi:10.1136/thx.46.5.355 · Cited by 86
Molfino, N. A., Slutsky, A. S., Juliá-Serdà, G., Hoffstein, V., Szalai, J. P., Chapman, K. R., Rebuck, A. S., & Zamel, N. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1238 · Cited by 86
Brunnée, T., Engelstätter, R., Steinijans, V., et al. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05080982 · Cited by 84
Inhaled Combination Therapy With Long-Acting β 2 -Agonists and Corticosteroids in Stable COPD
Cazzola, M., & Dahl, R. (2004) · CHEST Journal · doi:10.1378/chest.126.1.220 · Cited by 83
Self-citation
Cited by
β 2 -Agonist Therapy in Lung Disease
Cazzola, M., Page, C. P., Rogliani, P., & Matera, M. G. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1739pp · Cited by 262
Self-citationSoukup, O., Winder, M., Killi, U. K., Wsol, V., Jun, D., Kuca, K., & Tobin, G. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160607212615 · Cited by 34
Metadata
- Authors
- Cazzola, M., Page, C. P., Calzetta, L., & Matera, M. G.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 64
- Issue
- 3
- Pages
- 450-504
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2102590607
- Cited by
- 467
- References
- 315
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.